
GENERAL STUDIES
cfDNA and liquid biopsy - a novel diagnostic approach for melanocytic tumors. (W16-011)
Principal Investigators: Barbara Nell, DECVO, Jessica Rushton DVM; Clinic of Small Animal Surgery, Dentistry and Ophthalmology, Vetmeduni Vienna; $5,188.
Efficacy of a new treatment for cats with ronidazole-resistant Tritrichomonas foetus infection. (W16-053)
Principal Investigators: Jody Gookin, DVM,PhD, DACVIM, Mark Papich, DVM, MS, ACVCP; North Carolina State University College of Veterinary Medicine; $24,585.
Precision Medicine for Felines. (W16-030)
Principal Investigators: Leslie A. Lyons, PhD, Barbara Gandolfi, PhD; University of Missouri; $4,900 (Anonymous Sponsors)
BRIA FUND STUDIES
Evaluating new drug compounds for treating feline coronavirus, a continuation study. (W16-022)
Principal Investigators: Brian Murphy, DVM, PhD, ACVP; Niels Pedersen, DVM, PhD; University of California, Davis; $12,175
Mefloquine's potential to inhibit FIPV infection in the cat.(W16-023)
Principal Investigators: Merran Govendir,BVSc, PhD, Jacqueline Norris, BVSc, PhD; The University of Sydney, Australia; $11,750
Exploring humoral responses to non-structural proteins of feline coronaviruses. (W16-024)
Principal Investigator: Magdalena Dunowska, BVsc, PhD; Massey University, New Zealand; $25,000
RICKY FUND STUDY
Holter monitoring in the home environment for cats with hypertrophic cardiomyopathy. (W16-038)
Principal Investigator: Katherine Scollan, DVM, DACVIM, Oregon State University; $16,330
ABYSSINIAN HEALTH FUND STUDY
Seeking genetic markers of Abyssinian/Somali hereditary amyloidosis. (W16-028)
Principal Investigators: Maria Longheri, DVM, PhD, University of Milan; Leslie A. Lyons, PhD, University of Missouri; $6,900
PERSIAN HCM FUND STUDY
Evaluation of DNA variants associated with hypertrophic cardiomyopathy in the Persian cat. (W16-034)
Principal Investigator: Kathryn Meurs, DVM, PhD, DACVIM; North Carolina State University; $23,531.
BIRMAN HEART DISEASE FUND STUDY
Phenotypic characterization of cardiomyopathy in Birman cats - a phase two continuation study. (W16-040)
Principal Investigator: Virginia Luis Fuentes, VetMB, PhD, DACVIM, DECVIM; Royal Veterinary College, University of London; $10,812